Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MCHR1 | Q99705 | 8/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MCHR2 | Q969V1 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TERT | O14746 | 1/20 | 0.38 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4008079 | 1.00 | MAPT (0.41) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL14209942 | 0.95 | MAPT (0.40) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL4011914 | 0.91 | DCUN1D1 (0.47) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL4009965 | 0.91 | DCUN1D1 (0.47) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL4011939 | 0.87 | SMN1; SMN2 (0.40) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL4011944 | 0.87 | SMN1; SMN2 (0.40) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL5102537 | 0.80 | MAPT (0.43) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL4014945 | 0.80 | MAPT (0.43) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL3859191 | 0.80 | TRPV1 (0.44) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL4008953 | 0.80 | SMN1; SMN2 (0.45) | MAPTSMN1; SMN2LMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7351719-B2 | Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2008-04-01 | — | — | US | disclosed |
| US-20040152742-A1 | Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152742-A1 | Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds | MCHR2, MCHR1, NPY1R | MAPT 4346/4885SMN1; SMN2 2811/4885LMNA 4261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.